BCG制作PPT模板.pptVIP

Adding your slide to this collection Send your slide via e-mail to one of the following addresses propper.barbara@ kossmann.ines@ laubach.friedemann@ Thank you! Five types of slides We recommend entering this market segmentHigh growth and synergy with existing business make this an attractive opportunity Portfolio review at €5B industrial conglomerate resulting in split of company Project examples in corporate strategy Increased demand has stressed Artemisinin supply chain Different organizational models may beappropriate for different retailers Additional requirements to sell throughcatalogue sellers have to be met We win where we invest Health care spending increases with economic growth Model predicts ~ $35M upfront payment for compound X Early phases of development are getting longer Phase II trials are getting bigger Emerging markets: a potential source of inexpensive labor Comparable product typically spend ~ $70M pre-launch Top-down estimate Agricultural input only small part of food value chains value-added No clear champion can yet be identified across segments Opportunities exist in rapidly growing motorcycle market Innovative production will increase uptake of Artemisinin based malaria therapy Wide variability in shareholder returns Tool illustration 2: ready-willing-able audit Customer perspective compared to relative performanceExample of customer scorecard With lower variability cycle time can be decreased Long lead times caused by well-padded supply chain Position-strengthening strategies varyExamples of successful expansions Large breadth and depth of coverage Are the best-performing employees being rewarded?Performance versus total compensation Breakdown of channel partner financial incentives Discovery teams plan to triple revenue by 2006Only 25% of revenue in 2006 (two years after case) from new products/services Addressable biomedical RD market ~ $17BBased on CMC, overhead, FTE, and Capex assumptions Recent Fisher acquisition